Oracle Health Sciences

Articles

Exclusivity or Collaboration in Clinical Trials - What's the Best Formula for Success?

*** Monday, May 24, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST *** Most organizations deal with the vulnerabilities that exclusive point solutions create. Join industry leaders Oracle and IQVIA to understand how inclusivity and a flexible environment can help you employ new approaches faster, and the benefits of collaboration in today’s clinical trials ecosystem.*** On demand available after final airing until May 24, 2022 ***

How to Build Productive, Strategic Sponsor-CRO Partnerships

***Live: Tuesday, April 27, 2021 at 1pm EDT | 12pm CDT | 10am PDT*** Making the sponsor-CRO collaboration as productive as possible means continuing the transition away from tactical projects toward strategic partnerships with both stakeholders having vested interest in greater operational efficiency. However, many sponsor-CRO interactions are still fraught with inefficiencies and needless duplication of task ownership. How can these issues be addressed? ***On demand available after final airing until Apr. 27, 2022***

How to Work with Your CRO to Significantly Improve Clinical Trial Management and the Bottom Line

***Live: Tuesday, Oct. 20, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST*** Join Oracle Health Sciences and Michele Taylor-Scott, Head of Data Management at Health Decisions as they discuss why it is important for small to medium sized pharma and biotechs need to understand the technology landscape in order to work as educated partners with their CROs to help determine the most effective, fit-for-purpose solution for their clinical trials. Learn how a unified platform can help build a full study in a matter of weeks and reduce the overall time it takes to bring a drug to market. ***On demand available after final airing until Oct. 20, 2021***

COVID-19’s Impact on the Digital Transformation of Clinical Trials

COVID-19 has accelerated digital transformation roadmaps at sponsors and CROs, as well as, the adoption of new innovation strategies to respond to the realities of shelter-in-place directives. This immediate impact on patient recruitment and retention, is now being overshadowed by the opportunities presented to reimagine and reinvigorate studies, to overcome adversary to reap significant benefits now – and in the future. Live: Tuesday, Sept. 29, 2020 at 1pm EDT | 12 pm CDT | 10 am PDT On demand available after airing until Sept. 29, 2021.